FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2061573322> ?p ?o ?g. }

• W2061573322 endingPage "1473" @default.
• W2061573322 startingPage "1468" @default.
• W2061573322 abstract "SummaryBackground: The incidence of symptomatic venous thromboembolism (VTE) following hematopoietic stem cell transplantation (HSCT) is not well described, particularly with increased use of ambulatory care in the transplant setting. Methods: A retrospective analysis involving 589 patients (382 autologous HSCT, 207 allogeneic HSCT) undergoing transplantation between 2000 and 2005 in a single Canadian institution was undertaken to identify the incidence of proximal deep vein thrombosis (DVT) or pulmonary embolism (PE) in HSCT patients. Results: The total 1‐year incidence of symptomatic VTE was 3.7% [95% confidence interval (CI) 2.5–5.6]. Among the HSCT patients, 7/589 (1.2%, 95% CI 0.6–2.4) developed symptomatic non‐catheter‐related VTE following HSCT (four PE and three DVT). All VTE events occurred after hematopoietic engraftment. Patients undergoing autologous HSCT did not receive thromboprophylaxis, whereas most patients undergoing allogeneic HSCT (79.7%) received enoxaparin 20 mg daily for the prevention of veno‐occlusive disease of the liver, starting 6 ± 3 days before transplantation for a mean of 22 ± 14 days. Conclusion: HSCT patients have a high incidence of VTE. Thromboprophylaxis should potentially be considered in these patients. However, future studies assessing the risk and benefits of thromboprophylaxis are needed in this specific population. Background: The incidence of symptomatic venous thromboembolism (VTE) following hematopoietic stem cell transplantation (HSCT) is not well described, particularly with increased use of ambulatory care in the transplant setting. Methods: A retrospective analysis involving 589 patients (382 autologous HSCT, 207 allogeneic HSCT) undergoing transplantation between 2000 and 2005 in a single Canadian institution was undertaken to identify the incidence of proximal deep vein thrombosis (DVT) or pulmonary embolism (PE) in HSCT patients. Results: The total 1‐year incidence of symptomatic VTE was 3.7% [95% confidence interval (CI) 2.5–5.6]. Among the HSCT patients, 7/589 (1.2%, 95% CI 0.6–2.4) developed symptomatic non‐catheter‐related VTE following HSCT (four PE and three DVT). All VTE events occurred after hematopoietic engraftment. Patients undergoing autologous HSCT did not receive thromboprophylaxis, whereas most patients undergoing allogeneic HSCT (79.7%) received enoxaparin 20 mg daily for the prevention of veno‐occlusive disease of the liver, starting 6 ± 3 days before transplantation for a mean of 22 ± 14 days. Conclusion: HSCT patients have a high incidence of VTE. Thromboprophylaxis should potentially be considered in these patients. However, future studies assessing the risk and benefits of thromboprophylaxis are needed in this specific population." @default.
• W2061573322 created "2016-06-24" @default.
• W2061573322 creator A5004192896 @default.
• W2061573322 creator A5052393764 @default.
• W2061573322 creator A5054511215 @default.
• W2061573322 creator A5069180062 @default.
• W2061573322 creator A5071739915 @default.
• W2061573322 creator A5088493703 @default.
• W2061573322 date "2008-09-01" @default.
• W2061573322 modified "2023-10-11" @default.
• W2061573322 title "Incidence of symptomatic venous thromboembolism following hematopoietic stem cell transplantation" @default.
• W2061573322 cites W1527739777 @default.
• W2061573322 cites W1954992673 @default.
• W2061573322 cites W1966988081 @default.
• W2061573322 cites W1984947761 @default.
• W2061573322 cites W1989778990 @default.
• W2061573322 cites W1993293026 @default.
• W2061573322 cites W2022249597 @default.
• W2061573322 cites W2022932023 @default.
• W2061573322 cites W2036456888 @default.
• W2061573322 cites W2040207556 @default.
• W2061573322 cites W2058057039 @default.
• W2061573322 cites W2061293556 @default.
• W2061573322 cites W2071641311 @default.
• W2061573322 cites W2076827228 @default.
• W2061573322 cites W2083096614 @default.
• W2061573322 cites W2091880514 @default.
• W2061573322 cites W2103029594 @default.
• W2061573322 cites W2109113725 @default.
• W2061573322 cites W2109346271 @default.
• W2061573322 cites W2123818091 @default.
• W2061573322 cites W2132381095 @default.
• W2061573322 cites W2133619004 @default.
• W2061573322 cites W2313923699 @default.
• W2061573322 cites W2490019007 @default.
• W2061573322 cites W2618073389 @default.
• W2061573322 cites W4251527986 @default.
• W2061573322 cites W4376595850 @default.
• W2061573322 doi "https://doi.org/10.1111/j.1538-7836.2008.03077.x" @default.
• W2061573322 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18627443" @default.
• W2061573322 hasPublicationYear "2008" @default.
• W2061573322 type Work @default.
• W2061573322 sameAs 2061573322 @default.
• W2061573322 citedByCount "61" @default.
• W2061573322 countsByYear W20615733222012 @default.
• W2061573322 countsByYear W20615733222013 @default.
• W2061573322 countsByYear W20615733222014 @default.
• W2061573322 countsByYear W20615733222015 @default.
• W2061573322 countsByYear W20615733222016 @default.
• W2061573322 countsByYear W20615733222017 @default.
• W2061573322 countsByYear W20615733222018 @default.
• W2061573322 countsByYear W20615733222019 @default.
• W2061573322 countsByYear W20615733222020 @default.
• W2061573322 countsByYear W20615733222021 @default.
• W2061573322 countsByYear W20615733222022 @default.
• W2061573322 countsByYear W20615733222023 @default.
• W2061573322 crossrefType "journal-article" @default.
• W2061573322 hasAuthorship W2061573322A5004192896 @default.
• W2061573322 hasAuthorship W2061573322A5052393764 @default.
• W2061573322 hasAuthorship W2061573322A5054511215 @default.
• W2061573322 hasAuthorship W2061573322A5069180062 @default.
• W2061573322 hasAuthorship W2061573322A5071739915 @default.
• W2061573322 hasAuthorship W2061573322A5088493703 @default.
• W2061573322 hasBestOaLocation W20615733221 @default.
• W2061573322 hasConcept C120665830 @default.
• W2061573322 hasConcept C121332964 @default.
• W2061573322 hasConcept C126322002 @default.
• W2061573322 hasConcept C141071460 @default.
• W2061573322 hasConcept C167135981 @default.
• W2061573322 hasConcept C2776265017 @default.
• W2061573322 hasConcept C2777408962 @default.
• W2061573322 hasConcept C2780868729 @default.
• W2061573322 hasConcept C2908647359 @default.
• W2061573322 hasConcept C2911091166 @default.
• W2061573322 hasConcept C35785553 @default.
• W2061573322 hasConcept C61511704 @default.
• W2061573322 hasConcept C71924100 @default.
• W2061573322 hasConcept C99454951 @default.
• W2061573322 hasConceptScore W2061573322C120665830 @default.
• W2061573322 hasConceptScore W2061573322C121332964 @default.
• W2061573322 hasConceptScore W2061573322C126322002 @default.
• W2061573322 hasConceptScore W2061573322C141071460 @default.
• W2061573322 hasConceptScore W2061573322C167135981 @default.
• W2061573322 hasConceptScore W2061573322C2776265017 @default.
• W2061573322 hasConceptScore W2061573322C2777408962 @default.
• W2061573322 hasConceptScore W2061573322C2780868729 @default.
• W2061573322 hasConceptScore W2061573322C2908647359 @default.
• W2061573322 hasConceptScore W2061573322C2911091166 @default.
• W2061573322 hasConceptScore W2061573322C35785553 @default.
• W2061573322 hasConceptScore W2061573322C61511704 @default.
• W2061573322 hasConceptScore W2061573322C71924100 @default.
• W2061573322 hasConceptScore W2061573322C99454951 @default.
• W2061573322 hasIssue "9" @default.
• W2061573322 hasLocation W20615733221 @default.
• W2061573322 hasLocation W20615733222 @default.
• W2061573322 hasOpenAccess W2061573322 @default.
• W2061573322 hasPrimaryLocation W20615733221 @default.
• W2061573322 hasRelatedWork W1981961296 @default.

• next